Literature DB >> 13094499

The influenza virus: its morphology, immunology, and kinetics of multiplication.

P von MAGNUS.   

Abstract

The morphology of influenza virus is described, and the properties of its two components, the elementary body and the soluble substance, differentiated. The relationship between the filamentous and spherical structures observed in the infected allantoic fluid is still obscure, but the filaments are thought to represent either a form of influenza virus or a stage in its multiplication.The antigenic constitution of A and B viruses is discussed and variations in the pattern of individual strains over the past two decades described. The author outlines his speculations on the origin and mechanism of these variations. Other differences in serological behaviour, such as non-specific inhibition and the avidity effect, are discussed.The results of experimental investigation, with various animal hosts, of the kinetics of influenza virus multiplication are reviewed, and the effects of such factors as incubation temperature and concentration of the seed virus considered. The bearing of these studies of enzymatic virus/host-cell interactions on the chemotherapeutic control of influenza is emphasized.

Entities:  

Keywords:  INFLUENZA VIRUSES

Mesh:

Year:  1953        PMID: 13094499      PMCID: PMC2554196     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  56 in total

1.  Inhibitors of influenza virus haemagglutination in normal animal sera.

Authors:  A A C SAMPAIO
Journal:  Bull World Health Organ       Date:  1952       Impact factor: 9.408

2.  An interpretation of the significance of influenza virus variation for the development of an effective vaccine.

Authors:  J E SALK
Journal:  Bull N Y Acad Med       Date:  1952-11

3.  The investigation of influenza and related viruses in the electron microscope, by a new technique.

Authors:  I M DAWSON; W J ELFORD
Journal:  J Gen Microbiol       Date:  1949-05

4.  The spread of influenza; evidence from 1950-1951.

Authors:  A ISAACS; C H ANDREWES
Journal:  Br Med J       Date:  1951-10-20

5.  Structure of the influenza virus; the relation between biological activity and chemical structure of virus fractions.

Authors:  L HOYLE
Journal:  J Hyg (Lond)       Date:  1952-06

6.  The multiplication of complement-fixing antigen and red-cell agglutinin in the chorio-allantoic membrane of fertile eggs inoculated with influenza virus.

Authors:  L HOYLE
Journal:  J Pathol Bacteriol       Date:  1952-04

7.  The role of l-methionine in virus propagation.

Authors:  W W ACKERMANN
Journal:  J Exp Med       Date:  1951-04-01       Impact factor: 14.307

8.  Strain-specific elements in influenza antigens.

Authors:  G K HIRST
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

9.  THE SIZE OF INFLUENZA VIRUS.

Authors:  W M Stanley
Journal:  J Exp Med       Date:  1944-03-01       Impact factor: 14.307

10.  BIOPHYSICAL PROPERTIES OF PREPARATIONS OF PR8 INFLUENZA VIRUS.

Authors:  M A Lauffer; W M Stanley
Journal:  J Exp Med       Date:  1944-12-01       Impact factor: 14.307

View more
  4 in total

1.  [Best suited method for culturing influenza, mumps and Newcastle virus in the allantois sack of a chicken embryo for the purpose of determining disinfectants].

Authors:  A GRAFE; H G HAUSSMANN
Journal:  Z Hyg Infektionskr       Date:  1957

2.  [An influenza complement fixation test for practical use].

Authors:  W HENNESSEN
Journal:  Z Hyg Infektionskr       Date:  1955

3.  Influenza pandemic periodicity, virus recycling, and the art of risk assessment.

Authors:  Walter R Dowdle
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

4.  A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability.

Authors:  Rupert Beale; Helen Wise; Amanda Stuart; Benjamin J Ravenhill; Paul Digard; Felix Randow
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.